Cargando…

Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation

PURPOSE: The Bragg peak located at the end of the ion beam range is one of the main advantages of ion beam therapy compared to X-Ray radiotherapy. However, verifying the exact position of the Bragg peak within the patient online is a major challenge. The goal of this work was to achieve submillimete...

Descripción completa

Detalles Bibliográficos
Autores principales: Schauer, Jannis, Wieser, Hans-Peter, Huang, Yuanhui, Ruser, Heinrich, Lascaud, Julie, Würl, Matthias, Chmyrov, Andriy, Vidal, Marie, Herault, Joel, Ntziachristos, Vasilis, Assmann, Walter, Parodi, Katia, Dollinger, Günther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670173/
https://www.ncbi.nlm.nih.gov/pubmed/36408153
http://dx.doi.org/10.3389/fonc.2022.925542
_version_ 1784832283457355776
author Schauer, Jannis
Wieser, Hans-Peter
Huang, Yuanhui
Ruser, Heinrich
Lascaud, Julie
Würl, Matthias
Chmyrov, Andriy
Vidal, Marie
Herault, Joel
Ntziachristos, Vasilis
Assmann, Walter
Parodi, Katia
Dollinger, Günther
author_facet Schauer, Jannis
Wieser, Hans-Peter
Huang, Yuanhui
Ruser, Heinrich
Lascaud, Julie
Würl, Matthias
Chmyrov, Andriy
Vidal, Marie
Herault, Joel
Ntziachristos, Vasilis
Assmann, Walter
Parodi, Katia
Dollinger, Günther
author_sort Schauer, Jannis
collection PubMed
description PURPOSE: The Bragg peak located at the end of the ion beam range is one of the main advantages of ion beam therapy compared to X-Ray radiotherapy. However, verifying the exact position of the Bragg peak within the patient online is a major challenge. The goal of this work was to achieve submillimeter proton beam range verification for pulsed proton beams of an energy of up to 220 MeV using ionoacoustics for a clinically relevant dose deposition of typically 2 Gy per fraction by i) using optimal proton beam characteristics for ionoacoustic signal generation and ii) improved signal detection by correlating the signal with simulated filter templates. METHODS: A water tank was irradiated with a preclinical 20 MeV proton beam using different pulse durations ranging from 50 ns up to 1 μs in order to maximise the signal-to-noise ratio (SNR) of ionoacoustic signals. The ionoacoustic signals were measured using a piezo-electric ultrasound transducer in the MHz frequency range. The signals were filtered using a cross correlation-based signal processing algorithm utilizing simulated templates, which enhances the SNR of the recorded signals. The range of the protons is evaluated by extracting the time of flight (ToF) of the ionoacoustic signals and compared to simulations from a Monte Carlo dose engine (FLUKA). RESULTS: Optimised SNR of 28.0 ± 10.6 is obtained at a beam current of 4.5 μA and a pulse duration of 130 ns at a total peak dose deposition of 0.5 Gy. Evaluated ranges coincide with Monte Carlo simulations better than 0.1 mm at an absolute range of 4.21 mm. Higher beam energies require longer proton pulse durations for optimised signal generation. Using the correlation-based post-processing filter a SNR of 17.8 ± 5.5 is obtained for 220 MeV protons at a total peak dose deposition of 1.3 Gy. For this clinically relevant dose deposition and proton beam energy, submillimeter range verification was achieved at an absolute range of 303 mm in water. CONCLUSION: Optimal proton pulse durations ensure an ideal trade-off between maximising the ionoacoustic amplitude and minimising dose deposition. In combination with a correlation-based post-processing evaluation algorithm, a reasonable SNR can be achieved at low dose levels putting clinical applications for online proton or ion beam range verification into reach.
format Online
Article
Text
id pubmed-9670173
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96701732022-11-18 Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation Schauer, Jannis Wieser, Hans-Peter Huang, Yuanhui Ruser, Heinrich Lascaud, Julie Würl, Matthias Chmyrov, Andriy Vidal, Marie Herault, Joel Ntziachristos, Vasilis Assmann, Walter Parodi, Katia Dollinger, Günther Front Oncol Oncology PURPOSE: The Bragg peak located at the end of the ion beam range is one of the main advantages of ion beam therapy compared to X-Ray radiotherapy. However, verifying the exact position of the Bragg peak within the patient online is a major challenge. The goal of this work was to achieve submillimeter proton beam range verification for pulsed proton beams of an energy of up to 220 MeV using ionoacoustics for a clinically relevant dose deposition of typically 2 Gy per fraction by i) using optimal proton beam characteristics for ionoacoustic signal generation and ii) improved signal detection by correlating the signal with simulated filter templates. METHODS: A water tank was irradiated with a preclinical 20 MeV proton beam using different pulse durations ranging from 50 ns up to 1 μs in order to maximise the signal-to-noise ratio (SNR) of ionoacoustic signals. The ionoacoustic signals were measured using a piezo-electric ultrasound transducer in the MHz frequency range. The signals were filtered using a cross correlation-based signal processing algorithm utilizing simulated templates, which enhances the SNR of the recorded signals. The range of the protons is evaluated by extracting the time of flight (ToF) of the ionoacoustic signals and compared to simulations from a Monte Carlo dose engine (FLUKA). RESULTS: Optimised SNR of 28.0 ± 10.6 is obtained at a beam current of 4.5 μA and a pulse duration of 130 ns at a total peak dose deposition of 0.5 Gy. Evaluated ranges coincide with Monte Carlo simulations better than 0.1 mm at an absolute range of 4.21 mm. Higher beam energies require longer proton pulse durations for optimised signal generation. Using the correlation-based post-processing filter a SNR of 17.8 ± 5.5 is obtained for 220 MeV protons at a total peak dose deposition of 1.3 Gy. For this clinically relevant dose deposition and proton beam energy, submillimeter range verification was achieved at an absolute range of 303 mm in water. CONCLUSION: Optimal proton pulse durations ensure an ideal trade-off between maximising the ionoacoustic amplitude and minimising dose deposition. In combination with a correlation-based post-processing evaluation algorithm, a reasonable SNR can be achieved at low dose levels putting clinical applications for online proton or ion beam range verification into reach. Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC9670173/ /pubmed/36408153 http://dx.doi.org/10.3389/fonc.2022.925542 Text en Copyright © 2022 Schauer, Wieser, Huang, Ruser, Lascaud, Würl, Chmyrov, Vidal, Herault, Ntziachristos, Assmann, Parodi and Dollinger https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Schauer, Jannis
Wieser, Hans-Peter
Huang, Yuanhui
Ruser, Heinrich
Lascaud, Julie
Würl, Matthias
Chmyrov, Andriy
Vidal, Marie
Herault, Joel
Ntziachristos, Vasilis
Assmann, Walter
Parodi, Katia
Dollinger, Günther
Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation
title Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation
title_full Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation
title_fullStr Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation
title_full_unstemmed Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation
title_short Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation
title_sort proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670173/
https://www.ncbi.nlm.nih.gov/pubmed/36408153
http://dx.doi.org/10.3389/fonc.2022.925542
work_keys_str_mv AT schauerjannis protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT wieserhanspeter protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT huangyuanhui protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT ruserheinrich protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT lascaudjulie protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT wurlmatthias protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT chmyrovandriy protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT vidalmarie protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT heraultjoel protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT ntziachristosvasilis protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT assmannwalter protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT parodikatia protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation
AT dollingergunther protonbeamrangeverificationbymeansofionoacousticmeasurementsatclinicallyrelevantdosesusingacorrelationbasedevaluation